Cralonin
Cralonin oral vial
FULL PRESCRIBING INFORMATION: CONTENTS*
- CRALONIN DESCRIPTION
- INDICTION AND USAGE
- CRALONIN DOSAGE AND ADMINISTRATION
- CRALONIN CONTRAINDICATIONS
- WARNINGS AND PRECAUTIONS
- CRALONIN ADVERSE REACTIONS
- OVERDOSAGE
- CLINICAL PHARMACOLOGY
- Dosage
FULL PRESCRIBING INFORMATION
CRALONIN DESCRIPTION
Each 1.1 ml ampule contains:
|
Ingedient |
Potency |
Quantity |
|
Crataegus oxyacantha |
2X |
11µ |
|
Spigelia anthelmia |
1X |
11µ |
|
Kali carbonicum |
2X |
11µ |
Inactive Ingedient: Isotonic Sodium chloride solution
INDICTION AND USAGE
Cralonin indicated for the ancillary treatment of myocardial weakness
CRALONIN DOSAGE AND ADMINISTRATION
Adults: In general, 1 vial 1-3 times daily orally by mouth.
CRALONIN CONTRAINDICATIONS
Cralonin oral vials are contraindicated in patients with known sensitivity to Cralonin or any of its ingerdients.
WARNINGS AND PRECAUTIONS
Warnings and Precautions
None
CRALONIN ADVERSE REACTIONS
No adverse events have been reported with a casual relationship to Cralonin oral vials
OVERDOSAGE
Overdosage: No negative effects of an overdose have been reported
CLINICAL PHARMACOLOGY
Mechanism of Action
The exact mechanism of Cralonin oral vial is not fully understood
Dosage
1 oral vial containing 1.1 ml solution for oral administration
CraloninCRATAEGUS LAEVIGATA FLOWER, SPIGELIA ANTHELMIA and POTASSIUM BROMIDE SOLUTION
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
